Pureos Bioventures

Pureos Bioventures investment thesis

Prof. Dr. Thomas Baumert Advisory Board Thomas is a founder and advisor of Alentis Therapeutics and is an internationally renowned gastroenterologist with 25 years of R&D experience in fundamental, translational and clinical research. Thomas developed novel preventive and therapeutic strategies for fibrosis and cancer as well as underlying viral diseases. He has published more than 400 articles in leading scientific journals and led more than 50 research programs in fibrosis, cancer and virology. He is a Professor of Medicine, Gastroenterologist and head of the Inserm Institute IVH at the University of Strasbourg, France. He previously held positions at the Universities of Freiburg and Munich, the Massachusetts General Hospital/Harvard Medical School and the US National Institutes of Healt

Pureos Bioventures team (8)

Partners and principals at Pureos Bioventures:

• Klaus Breiner — sweet spot $1.5M
• Ximing Ding — sweet spot $1.5M
• Dominik Escher — sweet spot $1.5M
• Veronica Gambillara Fonck — sweet spot $1.5M
• Dragan Grabulovski — sweet spot $1.5M
• Anne Grahl — sweet spot $1.5M
• Martin Münchbach — sweet spot $1.5M
• Lars Nieba — sweet spot $1.5M

Is Pureos Bioventures a fit for your round?

Upload your pitch deck and see whether anyone at Pureos Bioventures appears in your top matches.